ASHTON DUET: Open Payments
NPI 1356936033 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $744 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $17 |
Products named: FARXIGA, Vanrafia, Kerendia, JYNARQUE, Fabhalta, IBSRELA, LOKELMA.
Industry payments across LA — which companies pay providers there.
